tus insignias Rango 52S $1–$3 89% of range Calificación del Analista BUY 14 analysts Precio Objetivo $2 P/E -6.2 ROE -929.3% Margen de Beneficio Neto -82.5%

PACB Instantánea de la Acción Precio, capitalización bursátil, P/E, BPA, ROE, deuda/capital, rango de 52 semanas

03
Precio $2.54
Capitalización Bursátil (MRQ) $789M
P/E (TTM) -6.2
BPA (TTM) $-0.41
Ingresos (TTM) $159M
ROE (TTM) -929.3%
Rango 52S $1–$3

PACB Gráfico del Precio de la Acción OHLCV diario con indicadores técnicos — desplace, amplíe y personalice su vista

04
rango
barras

La granularidad de las barras se adapta al período seleccionado; pase el ratón sobre el gráfico para ver la apertura/máximo/mínimo/cierre de una barra.

Acerca de Pacific Biosciences of California, Inc. - Common Stock Descripción general de la empresa de Wikipedia

05 · wikidata

Pacific Biosciences of California, Inc. (a.k.a. PacBio) is an American biotechnology company founded in 2004 that develops and manufactures systems for gene sequencing and some novel real time biological observation. PacBio has two principal sequencing platforms: single-molecule real-time sequencing (SMRT), based on the properties of zero-mode waveguides and sequencing by binding (SBB) chemistry, which uses native nucleotides and scarless incorporation for DNA binding and extension.

History

The company was founded based on research done at Cornell University that combined semiconductor processing and photonics with biotechnology research. Three graduate students in the lab of Professors Watt W. Webb — Jonas Korlach — and Harold Craighead — Steve Turner and Mathieu Foquet — became the first employees.

It began under the name Nanofluidics, Inc. The company raised nearly US$400,000,000 in six rounds of primarily venture capital financing, making it one of the most capitalized startups in 2010 leading up to their public offering in October of that year. Key investors included Mohr Davidow Ventures, Kleiner, Perkins, Caufield & Byers, Alloy Ventures, and Wellcome Trust.

The company's first commercial product, the PacBio RS, was sold to a limited set of customers in 2010 and was commercially released in early 2011. A subsequent version of the sequencer called the PacBio RS II was released in April 2013.

Leadership

In 2004, Kleiner Perkins entrepreneur-in-residence Hugh Martin became CEO. On 6 January 2012 board member Michael Hunkapiller, PhD assumed the role of CEO. Hunkapiller retired in September 2020, and was replaced by chairman of the board Christian Henry. Henry was a former executive VP and chief commercial officer of Illumina before joining the board at PacBio in July 2018.

Illumina: attempted acquisition

On 1 November 2018, Illumina, Inc. agreed to purchase PacBio for US$1.2 billion in cash. The deal was expected to close in the fourth quarter of 2019. In December 2019, the Federal Trade Commission sued to block the acquisition. The deal was abandoned with an announcement on 2 January 2020. Illumina further agreed to pay Pacific Biosciences a $98 million US termination fee plus previously agreed upon deal extension payments of $22 million US in February and $6 million US in March 2020.

Sequencing technology

Sequencing instruments

The company's first scientific instrument, called the PacBio RS, was released to a limited set of customers in late 2010., with full commercial release in early 2011. Sequencing provider GATC Biotech was selected by Pacific Biosciences as its first European service provider in late 2010. A new version of the sequencer was released in April 2013 it produced longer sequence reads and higher throughput than the original RS instrument. The RS instrument will officially be supported until the end of 2021. In September 2015, the company released a new sequencing instrument, the Sequel System, with increased sequencing capacity at a smaller size and lower price compared to the PacBio RS II. Subsequently, in October 2022, PacBio launched a new sequencing system, which can sequence 1,300 human genomes per year as compared to 86 per year of the previous PacBio sequencing machines.

Reagents and SMRT Cells

To use either instrument, customers must also purchase reagent packs for DNA preparation and sequencing and small consumables called "SMRT Cells." Cells for early forms of the sequencer are slightly less than one-centimeter square and contains tens of thousands of zero-mode waveguides, whereas newer systems have a higher density of cells and contain 25 million zero-mode waveguides (ZMWGs), allowing for faster DNA sequencing.

Software and applications

Their secondary analysis bioinformatics product for the RS, called “SMRT Analysis”, was open source. For the Sequel system the secondary analysis software was reorganized as the "SMRT Link" application. In 2013, the company released new bioinformatics tools for automated genome assembly (HGAP) and finishing (Quiver).

Fuente: Wikipedia (Inglés), CC BY-SA 4.0 · Ver en Wikipedia ↗

Wikidata ↗

sectorHealthcare industriaLife Sciences Tools & Services empleados485 paísUS

Rendimiento a 10 años Tendencias de ingresos, beneficio neto, márgenes y BPA

06
Ingresos$160M
2016-12-31 → 2025-12-31
BPA$-1.82
2018-12-31 → 2025-12-31
Flujo de caja libre$-114M
2016-12-31 → 2025-12-31
Margen neto-82.5%
2016-12-31 → 2025-12-31
Valoración y ratios 07–12

Valoración Ratios P/E, P/S, P/B, EV/EBITDA: ¿está la acción cara o barata?

Métrica Tendencia a 5 años PACB promedio 5A Mediana de Pares Veredicto
P/E (TTM) -6.2promedio 5A ≈-7.8 ≈-7.8 · ·
P/S (TTM) 5.0promedio 5A ≈13.8 ≈13.8 4.6 Infravalorado
P/C (MRQ) -23.8promedio 5A ≈23.9 ≈23.9 · ·
Precio / FCF (TTM) -6.4promedio 5A ≈-12.5 ≈-12.5 · ·
Precio / Flujo de Caja (TTM) -6.7promedio 5A ≈-13.1 ≈-13.1 · ·
Precio / Valor Contable Tangible (MRQ) -17.1 · · ·

La mediana de empresas comparables se calcula sobre una base estandarizada por métrica y puede no coincidir siempre con la base TTM/MRQ que se muestra para esta acción.

valor · ≈ promedio 5A · mediana sectorial · veredicto relativo a la mediana

Historial de Ganancias EPS real vs estimado, sorpresa %, tasa de aciertos, próxima fecha de resultados

14
Sorpresa Media -97.7%
Próximo informe Nov 03, 2026
PeríodoInformeEPS ActualEPS est.Sorpresa
30 de junio de 2026 Ago 3, 2026 $-0.14 $-0.13 -7.9%
31 de marzo de 2026 $-0.12 $-0.14 12.7%
31 de diciembre de 2025 $-0.12 $-0.15 20.3%
30 de septiembre de 2025 $-0.13 $-0.15 16.1%
30 de junio de 2025 $-0.14 $-0.17 19.3%
31 de marzo de 2025 $-1.44 $-0.19 -646.9%

Fundamentales Completos Todas las métricas por año — estado de resultados, balance general, flujo de caja

15
Estado de resultados 17
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue $160M$154M$201M$128M$131M$79M$91M$79M$93M$91M$93M$61M
Cost of Revenue $114M$117M$148M$79M$72M$46M$56M$54M$59M$47M$39M$37M
Gross Profit $46M$37M$53M$49M$59M$33M$35M$25M$35M$44M$53M$23M
R&D Expense $97M$135M$187M$193M$113M$64M$60M$63M$65M$68M$60M$48M
SG&A Expense $141M$175M$170M$161M$124M$73M$75M$63M$59M$48M$45M$38M
Operating Expenses $600M$512M$387M$356M$269M$137M$135M$126M$124M$115M$83M$86M
Operating Income $-554M$-474M$-334M$-307M$-210M$-104M$-101M$-101M$-90M$-71M$-29M$-63M
Interest Expense ··$14M$15M$13M$267.0K$3M$2M$3M$3M$3M$3M
Other Non-op $15M$24M$33M$8M$93.0K$2M$1M$848.0K$516.0K$103.0K$364.0K$-478.0K
Pretax Income $-546M$-310M$-318M$-314M$-275M$29M$-84M·····
Income Tax $318.0K$316.0K$-11M$0$-94M·······
Net Income $-546M$-310M$-307M$-314M$-181M$29M$-84M$-103M$-92M$-74M$-32M$-66M
EPS (Basic) $-1.82$-1.13$-1.21$-1.40$-0.89$0.18$-0.55$-0.76····
EPS (Diluted) $-1.82$-1.59$-1.21$-1.40$-0.89$0.17$-0.55$-0.76····
Shares (Basic) 299,959,000274,488,000253,629,000224,550,000204,136,000165,187,000152,527,000135,094,000····
Shares (Diluted) 299,959,000288,366,000253,629,000224,550,000204,136,000174,970,000152,527,000135,094,000····
EBITDA $-554M$-474M$-334M$-307M$-210M$-104M$-101M$-94M$-81M$-67M$-25M$-59M
Balance general 30
Métrica Tendencia 202520242023202220212020201920182017201620152014
Cash & Equivalents $64M$55M$180M$325M$461M$82M$30M$19M$17M$17M$34M$36M
Short-term Investments $216M$335M$452M$447M$584M$237M$19M$84M$46M$55M$49M$65M
Receivables $35M$28M$37M$19M$24M$17M$15M$9M$13M$11M$5M$3M
Inventory $49M$59M$57M$50M$25M$14M$13M$18M$23M$16M$11M$11M
Prepaid Expense $11M$19M$17M$10M$7M$5M$3M$3M$2M$10M$12M$2M
Other Current Assets ········$931.0K$476.0K$741.0K$107.0K
Current Assets $375M$496M$742M$852M$1.10B$356M$81M$132M$102M$109M$111M$118M
PP&E (Net) $24M$31M$36M$42M$33M$25M$30M$34M$38M$15M$9M$7M
PP&E (Gross) $117M$112M$111M$107M$89M$75M$74M$71M$70M$52M$42M$37M
Accum. Depreciation $92M$82M$75M$65M$56M$50M$44M$37M$32M$37M$34M$30M
Goodwill $318M$318M$462M$410M$410M·······
Intangibles $15M$390M$457M$410M$411M·······
Other Non-current Assets $9M$9M$13M$11M$1M$43.0K$42.0K$43.0K$45.0K$10M$8M$29.0K
Total Assets $784M$1.26B$1.75B$1.77B$2.01B$414M$148M$170M$144M$138M$131M$124M
Accounts Payable $21M$17M$15M$12M$11M$4M$8M$7M$9M$8M$5M$6M
Accrued Liabilities $34M$23M$46M$33M$36M$17M$13M$13M$13M$17M$16M$11M
Short-term Debt ·$0$490.0K$2M$2M·$16M·····
Current Liabilities $73M$66M$95M$263M$72M$39M$49M$27M$29M$34M$38M$31M
Capital Leases $57M$15M$32M$41M$50M$38M$42M····$2M
Other Non-current Liabilities $0$546.0K$751.0K$1M$3M$752.0K···$2M$1M$2M
Total Liabilities $779M$754M$1.04B$1.20B$1.22B$78M$93M$56M$58M$53M$58M$69M
Long-term Debt ···$897M$896M·$16M$15M$14M$16M·$14M
Total Debt ·$0$490.0K$2M$2M·$16M·····
Common Stock $302.0K$294.0K$268.0K$227.0K$221.0K$192.0K$153.0K$150.0K$116.0K$93.0K$80.0K$74.0K
Paid-in Capital $2.70B$2.65B$2.54B$2.10B$2.01B$1.37B$1.12B$1.10B$966M$872M$787M$736M
Retained Earnings $-2.70B$-2.15B$-1.84B$-1.53B$-1.22B$-1.04B$-1.07B$-982M$-880M$-788M$-713M$-681M
AOCI $457.0K$422.0K$219.0K$-5M$-1M$85.0K$5.0K$-36.0K$-32.0K$5.0K$-7.0K$9.0K
Stockholders' Equity $5M$507M$701M$563M$791M$335M$55M$114M$86M$85M$74M$55M
Liabilities + Equity $784M$1.26B$1.75B$1.77B$2.01B$414M$148M$170M$144M$138M$131M$124M
Shares Outstanding 301,956,000294,418,000267,744,000226,505,000220,978,000192,294,000153,119,000150,244,000116,277,00092,677,00079,983,00073,927,000
Flujo de Efectivo 16
Métrica Tendencia 202520242023202220212020201920182017201620152014
D&A ·······$7M$8M$4M$4M$4M
Stock-based Comp $42M$71M$72M$79M$73M$18M$16M$23M$20M$20M$14M$10M
Deferred Tax $-546.0K$-205.0K$-11M$0$-94M·······
Amort. of Intangibles $369M$27M$8M$913.0K$0$0$0·····
Restructuring ·$13M··········
Other Non-cash ·······$6M$-4M$-17M$-34M$528.0K
Operating Cash Flow $-111M$-206M$-259M$-263M$-111M$20M$-78M$-66M$-68M$-68M$-48M$-51M
CapEx $3M$6M$9M$17M$6M$1M$3M$2M$10M$8M$3M$2M
Investing Cash Flow $115M$124M$5M$116M$-679M$-219M$62M$-38M$-2M$-15M··
Stock Issued $0$0$189M$0$32M$46M$9M$10M$9M$8M$7M$4M
Net Stock Activity $0$0$15M$11M$32M$46M$9M$10M$9M$8M$7M$4M
Financing Cash Flow $3M$-43M$109M$10M$1.17B$252M$27M$107M$69M$66M··
Net Change in Cash $8M$-125M$-146M$-138M$380M···$-258.0K$-17M$-3M$10M
Taxes Paid $481.0K$256.0K$140.0K·········
Free Cash Flow $-114M$-212M$-268M$-280M$-117M$18M$-81M$-68M$-78M$-76M$-51M$-53M
Levered FCF ··$-282M·$-125M·······
Rentabilidad 8
Métrica Tendencia 202520242023202220212020201920182017201620152014
Gross Margin 28.6%24.2%26.3%38.2%45.1%41.3%38.0%31.9%37.1%48.7%57.6%38.6%
Operating Margin -346.1%-308.0%-166.8%-239.4%-161.2%-132.3%-110.6%-128.4%-96.1%-78.5%-31.4%-103.7%
Net Margin -341.5%-201.2%-153.0%-244.9%-138.8%37.3%-92.6%-130.4%-98.6%-82.0%-34.2%-109.2%
Pretax Margin -341.3%-201.0%-158.7%-244.9%-210.6%·······
EBITDA Margin -346.1%-308.0%-166.8%-239.4%-161.2%-132.3%-110.6%-119.3%-87.0%-74.3%-27.4%-96.8%
ROA -53.4%-20.6%-17.5%-16.7%-15.0%10.5%-52.9%-65.2%-65.4%-55.3%-24.8%-50.7%
ROE -1634.9%-64.6%-41.9%-52.8%-22.2%12.7%-158.8%-83.4%-108.0%-94.0%-49.3%-106.6%
ROIC -10360.5%-93.7%-46.0%·-17.5%·······
Liquidez y Solvencia 4
Métrica Tendencia 202520242023202220212020201920182017201620152014
Current Ratio 5.17.57.83.215.49.21.64.93.53.22.93.7
Quick Ratio 4.36.37.03.014.98.71.34.12.72.52.33.3
Debt / Equity ·0.00.00.00.0·0.3·····
Interest Coverage ··-23.3-20.9-16.8-391.0-38.5-41.7-30.7-22.0-10.0-22.2
Eficiencia 3
Métrica Tendencia 202520242023202220212020201920182017201620152014
Asset Turnover 0.20.10.10.10.10.30.60.50.70.70.70.5
Inventory Turnover 2.12.02.82.13.73.43.62.63.03.53.53.5
Receivables Turnover 5.14.87.26.06.44.97.67.17.510.921.419.7
Por Acción 6
Métrica Tendencia 202520242023202220212020201920182017201620152014
Book Value / Share $0.02$1.72$2.62$2.49$3.58$1.74$0.36$0.76$0.74$0.91$0.92$0.74
Revenue / Share $0.53$0.53$0.79$0.57$0.64$0.45······
Cash Flow / Share $-0.37$-0.71$-1.02$-1.17$-0.54$0.11······
Cash / Share $0.21$0.19$0.67$1.44$2.08$0.42$0.19$0.13$0.14$0.18$0.42$0.49
Dividend / Share $0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
EPS (TTM) $-1.82$-1.59$-1.21$-1.40$-0.89$0.17$-0.55$-0.76····
Tasas de Crecimiento 3
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue YoY 3.9%-23.2%56.3%-1.7%65.4%·······
Revenue CAGR 3Y 7.6%5.7%36.5%·········
Revenue CAGR 5Y 15.2%···········
Valoración (TTM) 14
Métrica Tendencia 202520242023202220212020201920182017201620152014
Revenue TTM $160M$154M$201M$128M$131M$79M$91M$79M$93M$91M$93M$61M
Net Income TTM $-546M$-310M$-307M$-314M$-181M$29M$-84M$-103M$-92M$-74M$-32M$-66M
Market Cap $565M$539M$2.63B$1.85B$4.52B$4.99B$787M$1.11B$307M$352M$1.05B$580M
Enterprise Value ·$149M$2.00B$1.08B$3.48B·$754M·····
P/E -1.0-1.2-8.1-5.8-23.0152.6-9.3-9.7····
P/S 3.53.513.114.434.663.28.714.13.33.911.39.6
P/B 105.61.13.73.35.714.914.39.73.64.214.310.5
P / Tangible Book ·····14.9······
P / Cash Flow -5.1-2.6-10.1-7.0-40.7255.8-10.0-16.7-4.5-5.2-21.9-11.3
P / FCF -5.0-2.5-9.8-6.6-38.6270.2-9.7-16.3-3.9-4.6-20.6-10.9
EV / EBITDA ·-0.3-6.0-3.5-16.5·-7.5·····
EV / FCF ·-0.7-7.4-3.9-29.7·-9.3·····
EV / Revenue ·1.010.08.426.7·8.3·····
Earnings Yield -97.3%-86.9%-12.3%-17.1%-4.3%0.66%-10.7%-10.3%····

Período más reciente a la izquierda · valores nulos mostrados como ·

Estados Financieros Estado de resultados, balance general, flujo de caja — anual, últimos 5 años

16
Métrica 2025-12-312024-12-312023-12-312022-12-312021-12-31
Ingresos $160M $154M $201M $128M $131M
Margen Bruto % 28.6% 24.2% 26.3% 38.2% 45.1%
Margen Operativo % -346.1% -308.0% -166.8% -239.4% -161.2%
Beneficio neto $-546M $-310M $-307M $-314M $-181M
EPS Diluido $-1.82 $-1.59 $-1.21 $-1.40 $-0.89

Propietarios institucionales (13F) 244 declarantes · $360.0M total · A fecha de 30 de junio de 2026

17

Instituciones que informan tener esta acción en su Formulario 13F trimestral de la SEC. Solo posiciones largas; un solo presentador puede aparecer dos veces para tramos de opciones separados. Las patas de put/call de compensación grandes suelen reflejar la creación de mercado o el inventario cubierto, no la convicción direccional.

Tenedores 244
Valor en tenencia $360.0M
Nuevas posiciones 24
Posiciones cerradas 28
Actividad institucional — Q2 2026 vs trimestre anterior
Nuevas posiciones Posiciones cerradas Aumentado Disminuido Cambio neto de acciones
24 (-30 vs trimestre anterior) 28 (-2 vs trimestre anterior) 72 (+14 vs trimestre anterior) 80 (+4 vs trimestre anterior) +4.3M

Comparado con Q1 2026. Las presentaciones del Formulario 13F de la SEC vencen dentro de los 45 días posteriores al final del trimestre, más un pequeño margen para los presentadores tardíos; los trimestres que aún se encuentran dentro de esa ventana se omiten en favor del par más reciente completamente reportado.

Institución Valor Acciones % de 13F rastreadas Tipo
BlackRock, Inc. $54 330 444 32 339 550 15,09% Acciones
ARK Investment Management LLC $50 032 778 29 781 416 13,90% Acciones
SOFTBANK GROUP CORP. $34 358 638 20 451 570 9,54% Acciones
VANGUARD GROUP INC $31 859 776 17 037 314 8,85% Acciones
VANGUARD CAPITAL MANAGEMENT LLC $22 508 529 13 397 934 6,25% Acciones
GEODE CAPITAL MANAGEMENT, LLC $12 782 429 7 606 518 3,55% Acciones
Sumitomo Mitsui Trust Group, Inc. $10 096 321 6 009 715 2,80% Acciones
Amova Asset Management Americas, Inc. $10 036 224 6 009 715 2,79% Acciones
STATE STREET CORP $10 014 774 5 961 175 2,78% Acciones
Point72 Asset Management, L.P. $8 042 664 4 787 300 2,23% Acciones
TWO SIGMA INVESTMENTS, LP $7 127 566 4 242 599 1,98% Acciones
D. E. Shaw & Co., Inc. $7 069 686 4 208 146 1,96% Acciones
MILLENNIUM MANAGEMENT LLC $6 656 903 3 962 442 1,85% Acciones
Point72 (DIFC) Ltd $5 465 775 4 270 137 1,52% Acciones
GOLDMAN SACHS GROUP INC $5 426 210 3 229 887 1,51% Acciones
CITADEL ADVISORS LLC $4 781 117 2 845 903 1,33% Acciones
VANGUARD PORTFOLIO MANAGEMENT LLC $4 488 819 2 671 916 1,25% Acciones
CHARLES SCHWAB INVESTMENT MANAGEMENT INC $4 455 861 2 652 298 1,24% Acciones
NORTHERN TRUST CORP $3 952 681 2 352 786 1,10% Acciones
VANGUARD FIDUCIARY TRUST CO $3 675 213 2 187 627 1,02% Acciones
SUSQUEHANNA INTERNATIONAL GROUP, LLP $3 577 162 2 129 263 0,99% Acciones
Longaeva Partners L.P. $3 558 628 2 118 231 0,99% Acciones
IQ EQ FUND MANAGEMENT (IRELAND) Ltd $2 846 837 1 694 546 0,79% Acciones
Birchview Capital, LP $2 268 000 1 350 000 0,63% Acciones
BANK OF AMERICA CORP /DE/ $2 264 860 1 348 131 0,63% Acciones
Invesco Ltd. $2 179 114 1 297 091 0,61% Acciones
AQR CAPITAL MANAGEMENT LLC $2 178 430 1 296 684 0,61% Acciones
Nuveen, LLC $1 718 830 1 023 113 0,48% Acciones
RENAISSANCE TECHNOLOGIES LLC $1 623 216 966 200 0,45% Acciones
BOURNE LENT ASSET MANAGEMENT INC $1 584 332 943 055 0,44% Acciones
TWO SIGMA ADVISERS, LP $1 547 425 827 500 0,43% Acciones
HHLR ADVISORS, LTD. $1 543 739 918 892 0,43% Acciones
UBS Group AG $1 500 475 893 140 0,42% Acciones
Universal- Beteiligungs- und Servicegesellschaft mbH $1 358 616 808 700 0,38% Acciones
Bank of New York Mellon Corp $1 289 512 767 567 0,36% Acciones
DIMENSIONAL FUND ADVISORS LP $1 277 135 759 783 0,35% Acciones
Casdin Capital, LLC $1 215 929 723 767 0,34% Acciones
TUDOR INVESTMENT CORP ET AL $1 150 308 684 707 0,32% Acciones
XTX Topco Ltd $1 073 322 638 882 0,30% Acciones
Numerai GP LLC $1 044 068 621 469 0,29% Acciones
CARRET ASSET MANAGEMENT, LLC $1 008 235 600 140 0,28% Acciones
Man Group plc $1 003 521 597 334 0,28% Acciones
Russell Investments Group, Ltd. $1 002 694 596 843 0,28% Acciones
Balyasny Asset Management L.P. $948 090 564 339 0,26% Acciones
PEAK6 LLC $933 327 555 552 0,26% Acciones
Vestmark Advisory Solutions, Inc. $803 384 478 205 0,22% Acciones
MORGAN STANLEY $802 664 477 776 0,22% Acciones
ArrowMark Colorado Holdings LLC $786 882 468 382 0,22% Acciones
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. $741 954 441 639 0,21% Acciones
SUSQUEHANNA INTERNATIONAL GROUP, LLP $673 008 400 600 0,19% Opción de venta

Mostrar todos los 244 propietarios institucionales →

Activistas y propietarios del %+ 5 1 tenencia

18

Inversores que presentaron el Anexo 13D de la SEC — propiedad beneficiosa superior al % 5 con la intención de influir en el emisor (participaciones activistas, campañas de la junta directiva, M&A). Cada fila muestra el estado conocido más reciente de la posición de ese declarante.

Declarante Presentado Participación Estado Propósito Presentación
Magnetar Financial LLC, Magnetar Capital Partners LP, Supernova Management LLC, Alec N. Litowitz ×3 presentaciones 29 de agosto de 2019 · Presentación inicial · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Informantes de la empresa 30 insiders · 6 directivos · 11 consejeros

19
Insider Rol Última actividad Acciones en propiedad Compras 12m Ventas 12m Neto 12m
Mark Van Oene President & CEO 17 de agosto de 2026 S 2 705 853 0 4 $-335 122
Susan K Barnes EVP, CFO and PAO 19 de febrero de 2020 S 874 812 0 0 $0
James Michael Phillips SVP, Research & Development 24 de marzo de 2020 S 249 220 0 0 $0
Kevin P Corcoran SVP, Market Development 24 de noviembre de 2017 M 158 174 0 0 $0
Michael Glynn Chief Commercial Officer 15 de febrero de 2012 A · 0 0 $0
Stephen W Turner VP & Chief Technology Officer 11 de julio de 2011 J 1 093 063 0 0 $0
Christopher Gibson Consejero 3 de junio de 2026 A 111 386 0 0 $0
Hannah Valantine Consejero 3 de junio de 2026 A 22 821 0 0 $0
William W. Ericson Consejero 3 de junio de 2026 A 41 616 0 0 $0
Christopher M Smith Consejero 3 de junio de 2026 A 54 099 0 0 $0
Marshall Mohr Consejero 3 de junio de 2026 A 132 821 0 0 $0
Randall S Livingston Consejero 3 de junio de 2026 A 22 821 0 0 $0
Kathy Ordonez Consejero 3 de junio de 2026 A 403 037 0 0 $0
John F Milligan Consejero 3 de junio de 2026 A 132 821 0 0 $0
David B. Singer Consejero 13 de junio de 2012 A · 0 0 $0
Susan E Siegel Consejero 13 de junio de 2012 A 65 000 0 0 $0
Hugh C Martin Consejero 3 de febrero de 2012 M 342 458 0 0 $0
James R Gibson II · 1 de abril de 2026 S 1 245 663 0 1 $-120 813
Michele Farmer · 3 de marzo de 2026 S 305 948 0 3 $-84 510
Christian O Henry · 3 de marzo de 2026 S 3 581 813 0 3 $-772 728
Lucy Shapiro · 4 de junio de 2025 A 22 821 0 0 $0
Susan G. Kim · 30 de septiembre de 2024 S 695 654 0 0 $0
Jeff Eidel · 19 de agosto de 2024 S 869 730 0 0 $0
David W Meline · 18 de junio de 2024 A 57 116 0 0 $0
David Botstein · 24 de mayo de 2023 A 0 0 0 $0
Peter Fromen · 2 de marzo de 2022 A 190 280 0 0 $0
Michael Hunkapiller · 26 de febrero de 2021 M 848 405 0 0 $0
Eric Schaefer · 22 de febrero de 2021 S 88 474 0 0 $0
BYERS BROOK H · 17 de mayo de 2016 A 110 504 0 0 $0
Brian B Dow · 2 de marzo de 2015 P 18 119 0 0 $0

Informantes de las presentaciones SEC Form 3/4/5; neto = solo P/S de mercado abierto

Propiedad de ETFs Mantenido por 21 ETFs

20

El peso refleja solo las tenencias directas de acciones (N-PORT); los fondos apalancados o basados en derivados pueden tener exposición adicional a swaps no mostrada.

Fondo Ponderación Unidades A fecha de Fuente
ARKG · ARK ETF Trust 0,96% 10 630 263 NS 31 de julio de 2026 N-PORT
QQQS · Invesco Exchange-Traded Fund Trust … 0,91% 88 548 SH 1 de octubre de 2026 Diario
IDNA · iShares Trust 0,35% 711 655 SH 11 de septiembre de 2026 Diario
ARKK · ARK ETF Trust 0,32% 12 810 378 NS 31 de julio de 2026 N-PORT
PRFZ · Invesco Exchange-Traded Fund Trust 0,09% 1 001 721 SH 1 de octubre de 2026 Diario
IBBQ · Invesco Exchange-Traded Fund Trust … 0,05% 21 993 SH 1 de octubre de 2026 Diario
VTWG · VANGUARD SCOTTSDALE FUNDS 0,03% 280 941 SH 19 de agosto de 2026 Diario
IBB · iShares Trust 0,03% 2 192 352 SH 11 de septiembre de 2026 Diario
IWO · iShares Trust 0,02% 2 473 318 SH 11 de septiembre de 2026 Diario
RSSL · Global X Funds 0,01% 134 834 NS 31 de julio de 2026 N-PORT
IWM · iShares Trust 0,01% 7 217 251 SH 11 de septiembre de 2026 Diario
VXF · VANGUARD INDEX FUNDS 0,01% 3 579 782 SH 19 de agosto de 2026 Diario
VTWO · VANGUARD SCOTTSDALE FUNDS 0,01% 1 624 029 SH 19 de agosto de 2026 Diario
VHT · VANGUARD WORLD FUND 0,01% 727 094 SH 19 de agosto de 2026 Diario
ITOT · iShares Trust 0,00% 431 328 SH 11 de septiembre de 2026 Diario
IWV · iShares Trust 0,00% 69 680 SH 9 de septiembre de 2026 Diario
VTI · VANGUARD INDEX FUNDS 0,00% 9 535 565 SH 19 de agosto de 2026 Diario
VTWV · VANGUARD SCOTTSDALE FUNDS 0,00% 17 047 SH 19 de agosto de 2026 Diario
VTHR · VANGUARD SCOTTSDALE FUNDS 0,00% 22 805 SH 19 de agosto de 2026 Diario
DFAC · Dimensional ETF Trust 0,00% 8 144 NS 31 de julio de 2026 N-PORT
IWN · iShares Trust · 207 024 SH 11 de septiembre de 2026 Diario

PACB Consenso de analistas Opiniones de analistas alcistas y bajistas, precio objetivo a 12 meses, potencial alcista

21
calificación · 14 analistas COMPRA
Objetivo mediano $2.00 -21,3%
4 28,6% Compra fuerte
5 35,7% Compra
4 28,6% Mantener
1 7,1% Venta
0 0,0% Venta fuerte

Precio objetivo a 12 meses

7 analistas · 2026-10-02

Objetivo medio $2.16 -15,1%

Ahora Precio Actual $2.54
Mín$1.25 Media$2.16 Máx$3.00

Comparación de pares (subindustria GICS) Métricas clave frente a competidores del sector

22

Base del ejercicio fiscal, precios al cierre del último ejercicio fiscal de cada empresa.

Ticker Capitalización Bursátil P/E Ingresos interanuales Margen Neto ROE Margen Bruto
PACB $565M -1.0 3.9% -341.5% -1634.9% 28.6%
BLFS · -241.8 28.9% · · ·
PSNL $816M -8.7 -17.7% -116.7% -36.0% ·
AZTA $1.32B -23.5 3.5% -9.4% -3.3% 45.5%
CYRX $479M 6.9 12.4% 44.4% 15.3% 47.1%
DNA $484M -1.5 -25.1% -183.8% -55.8% ·
CTKB $649M 505.0 0.52% -33.0% -18.5% 51.8%
MLAB $489M 73.1 3.4% 2.7% 3.7% 63.5%
OABI · · · · · ·
TKNO $204M -11.9 7.3% -42.6% -23.8% 33.2%
QSI · · · · · ·

Mis Métricas Tu lista de seguimiento personal — filas seleccionadas de Fundamentales Completos

26

Seleccione las métricas que le importan: haga clic en el + junto a cualquier fila en Fundamentales completos arriba.

Tu selección se guarda y te sigue en todos los tickers.

Fuente: SEC 10-Q presentada el Ago 6, 2026